The Voice of the Voiceless
We are here to protect you from negligent companies and help you hold them accountable for the injuries you suffered.
877.806.2629
FDA issues a recall for two generic versions of Concerta
The U.S. Food and Drug Administration (FDA) recently proposed to withdraw two generic versions of the attention-deficit hyperactive disorder (ADHD) drug Concerta. Afer a two-year evaluation, the Center for Drug Evaluation and Research (CDER) determined that the...
Mississippi woman files a new Taxotere alopecia lawsuit
A new plaintiff filed a Taxotere lawsuit alleging that the chemotherapy agent caused her to permanently lose her hair and suffer from irreversible alopecia. The woman from Mississippi, Bessie Mae W., started her treatment with docetaxel in September 2009, shortly...
Judge Fallon postpones deadline to file a Xarelto lawsuit by 90 days
On September 21, 2016, Honorable Judge E. Fallon postponed by 90 days the deadline to file a Xarelto lawsuit in the current multidistrict litigation (MDL Number 2592). The number of new cases increased so steadily over the course of last few months, that the United...
Plaintiffs sue Bayer for Essure unintended pregnancies
Several plaintiffs recently filed an Essure lawsuit claiming they still faced unintended pregnancies even after being implanted with the contraceptive device. The number of litigations filed kept increasing in the last few months since Congresswoman Louise Slaughter...
Two Talcum Powder lawsuits dismissed by a Judge in New Jersey
Johnson & Johnson convinced a New Jersey Judge to dismiss two new talcum-ovarian cancer litigations. Plaintiffs who filed the two lawsuits blame the pharmaceutical giant for the ovarian malignancy they developed after using the controversial talcum powder for...
More than 50 Taxotere lawsuits filed by patients affected by hair loss
At least 50 individual victims who suffered permanent hair loss joined in a Taxotere litigation against Sanofi-Aventis, accusing the company of negligence in warning about the dangerous side effects of the chemotherapy agent. According to the plaintiffs' disputes, the...
FDA re-evaluates Essure clinical trial, confirms data provided by Bayer
The U.S. Food and Drug Administration announced the completion of previously announced investigation on Essure's clinical trial. The regulator reviewed all the case report forms provided by Bayer used to assess the safety and effectiveness of the controversial birth...
New Xarelto lawsuits being filed, Bayer keeps reaffirming drug’s safety
A new Xarelto lawsuit has been recently filed against Bayer AG and Janssen Pharmaceutical by a woman who lost his husband to the side effects of this dangerous blood thinner. Plaintiff Anita F. (Case No. 2:16-cv-14021) is seeking compensation in court on behalf of her...
Portola’s new Xarelto antidote has been rejected by the FDA
The drugmaker Portola Pharmaceuticals Inc. announced that on August 17, 2016, the Biologics License Application (BLA) of its new Xarelto antidote AndexXa™ (Andexanet alfa) has been rejected. AndexXa acts by substituting the human Factor Xa, stopping the action of...
